The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European gas inventories back to 10-year average

Wed, 17th Aug 2022 12:19

EUROPEAN GAS INVENTORIES BACK TO 10-YEAR AVERAGE (1117 GMT)

As well as watching trading screens, market players are keeping one eye on European gas supplies as a key metric when weighing up the economic outlook.

According to UBS analysts, European gas storage usage reached its 10-year average at the beginning of August.

As of August 13, storage was 74% full - above last year's level of 61%. At this rate, by the end of October storage levels could be near to 90%, the analysts said in a note.

We can thank liquid natural gas imports for that.

"Imports (of LNG) were up 110% y/y in July and are up 61% y/y YTD which helps to offset low volumes from Russia," they said in a note.

On the other hand, Russian exports have continued to decline.

"In 1H Aug Gazprom exports to Europe stood at ~2.6bcm, down 64% y/y, close to the July daily average."

The analysts said they expect LNG imports in Europe to remain close to first half levels in the second half, but that "risks are to the downside", with potentially more competition from Asian buyers and risk of supply disruptions.

"And these come at a high price, TTF (front-month) approaching €250/MWh today."

STOXX 600: NOT MUCH TO EXPECT FROM EARNINGS NOW (0926 GMT)

The better-than-expected Q2 earnings season, along with a weaker euro, was an essential driver of the summer rally which has lifted the pan-European STOXX 600 over 10% since the June lows.

But as you see can below from the latest Refinitiv I/B/E/S estimates, profit growth is expected to reverse into an earnings recession in 2023:

Moving forward, European stocks, still down over 9% year-to-date, will therefore not likely be able to count on earnings to rebound further this year.

"Q2 earnings have not been the disaster some had predicted, but mixed guidance, high inventories and rising margin pressures offer little comfort", Barclays strategists argued in a note.

So with little to expect from earnings growth, multiples need to expand for the rally to keep on going.

"As slowing growth caps the upside to FY estimates, at best, the bull case for equities relies on renewed P/E expansion", they wrote, calling such a re-rating "elusive".

Then again, as they show in this chart, the low level of European price-to-earnings ratios seems to suggest that there is potentially some upside:

(Julien Ponthus)

STOXX SET FOR SIXTH CONSECUTIVE DAY OF GAINS (0753 GMT)

European shares are into their sixth consecutive day of gains, with the STOXX 600 opening 0.3% higher as markets continue to brush off fears of an energy crisis and recession on the continent.

The financial services sector is leading gains with a 0.88% rise, while healthcare and basic resources are ringing in at the bottom, down 0.22% and 0.35% respectively.

Shares in Uniper are falling 8.2% and are at the bottom of the STOXX 600, unsurprising given the company just reported a hefty 12 billion euro loss in the first half .

Shares in GSK are down 2.1% but stayed above recent lows after the plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial agreed to drop his case .

At the top of the index is Swiss laboratory instruments maker Tecan Group, surging 12% after a H1 beat and raising its FY sales outlook.

MORE DOOM AND GLOOM LOOMS FOR EUROPE (0640 GMT)

Europeans will be hoping Wednesday’s economic data will provide some respite after a string of negative headlines, but past form suggests they’d be foolish to bet too much on it.

They might even be better off taking a punt on depressing figures, as at least their winnings might provide some small cheer if the bad news arrives.

British consumer price inflation jumped to 10.1% in July, its highest since February 1982, up from an annual rate of 9.4% in June, intensifying the squeeze on households, official figures showed on Wednesday

That’s not good news for British workers who saw earnings for the second quarter adjusted for inflation fall by 4.1%, the biggest drop since records began in 2001, according to data released on Tuesday.

The final reading for Euro zone Q2 GDP is also due on Wednesday, and while preliminary data showed faster than expected growth, even then economists said it might be the economy's last hurrah.

If data from down under offers any clues, they aren’t great.

Earlier on Wednesday New Zealand’s Central Bank signalled a more hawkish tightening path over coming months to restrain stubbornly high inflation, even as it delivered its seventh straight interest rate hike, and Australian wage growth missed forecasts and lagged badly behind inflation.

The kiwi dollar initially climbed on the news before giving up its gains, though the Aussie held onto its losses.

Asian shares eked out small gains in morning trading, following overnight gains on Wall Street, where economic data is less depressing.

Japan was in the lead with the Nikkei up 1%, while MSCI’s broadest index of shares outside Japan rose just 0.2%.

Key developments that could influence markets on Wednesday:

UK Jul CPI, Jul PPI

Euro zone Q2 flash employment, Q2 GDP

US Jul retail sales

US 20-year Treasury auction

Fed Reserve releases minutes from July policy meeting at 1800 GMT

New Zealand's central bank meeting and press conference.

European earnings: Swiss Life, Carlsberg, Uniper

US earnings: Lowe’s, Target, Cisco

(Alun John)

WHAT ECONOMIC GLOOM?: (0629 GMT)

European shares look set for their sixth consecutive day of rises, with futures contracts signalling increases of 0.3% as they track U.S. shares which posted gains on Tuesday after some strong showings from major retailers.

U.S. retail sales data will give a further insight today but in the meantime there are some not so pretty earnings coming out of Europe to contend with.

Danish brewer Carlsberg reported Q2 sales below expectations, while Germany's Uniper, which secured a 15 billion euro bailout last month, reported a net loss of more than 12 billion euros ($12.2 billion) for the first half.

Better news is coming from insurer Swiss Life which has increased its half year net profit by 4%.

On the data front, UK CPI was seen rising to the highest level since 1982, up to 10.1% in July from 9.4% in June.

(Lucy Raitano)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.